Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects

Siegfried Kasper, Markus Dötsch, Hermes Kick, Antonio Vieira, Hans-Jürgen Möller
  • European Neuropsychopharmacology, March 1993, Elsevier
  • DOI: 10.1016/0924-977x(93)90290-3

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/0924-977x(93)90290-3

The following have contributed to this page: Hans-Juergen Moeller